Abstract
The purpose of this study is to report our institutional experience using radiotherapy in the treatment of ameloblastoma and ameloblastic carcinoma. Three patients with ameloblastoma and 3 patients with ameloblastic carcinoma were treated with radiotherapy alone (2 patients) or surgery and postoperative radiotherapy (4 patients) at the University of Florida between 1973 and 2007. Follow-up ranged from 4.0 to 13.1 years with a median of 7.8 years. Radiotherapy complications were scored using the Common Terminology Criteria for Adverse Events, version 4.0. Local control was achieved in 4 of the 6 patients. One patient treated with RT alone for an unresectable ameloblastoma developed a local recurrence and metastases in both the cervical lymph nodes and lungs, but had excellent response to dual BRAF/MEK inhibition with dabrafenib and trametinib. Another patient treated with surgery and postoperative radiotherapy for an ameloblastic carcinoma recurred locally without metastasis, but was not salvaged. No significant treatment-related complications were observed. For patients with local recurrence or inadequate margins after surgery, adjuvant radiotherapy provides the potential for disease control. In the setting of metastatic disease, targeted therapies may provide an additional opportunity for salvage.
Similar content being viewed by others
References
Amzerin M, Fadoukhair Z, Belbaraka R, Iraqui M, Boutayeb S, M’Rabti H, Kebdani T, Hassouni K, Benjaafar N, El Gueddari BK, Errihani H (2011) Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature. J Med Case Rep 5:491. doi:10.1186/1752-1947-5-491
Wesley RK, Borninski ER, Mintz S (1977) Peripheral ameloblastoma: report of case and review of the literature. J Oral Surg 35:670–672
Becelli R, Carboni A, Cerulli G, Perugini M, Iannetti G (2002) Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. J Craniofac Surg 13:395–400 (discussion)
Ord RA, Blanchaert RH Jr, Nikitakis NG, Sauk JJ (2002) Ameloblastoma in children. J Oral Maxillofac Surg 60:762–770 (discussion 70–71)
Regezi JA, Kerr DA, Courtney RM (1978) Odontogenic tumors: analysis of 706 cases. J Oral Surg 36:771–778
Reichart PA, Philipsen HP, Sonner S (1995) Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 31B:86–99
Mehlisch DR, Dahlin DC, Masson JK (1972) Ameloblastoma: a clinicopathologic report. J Oral Surg 30:9–22
Slootweg PJ, Muller H (1984) Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 57:168–176
Laughlin EH (1989) Metastasizing ameloblastoma. Cancer 64:776–780
Van Dam SD, Unni KK, Keller EE (2010) Metastasizing (malignant) ameloblastoma: review of a unique histopathologic entity and report of Mayo clinic experience. J Oral Maxillofac Surg 68:2962–2974. doi:10.1016/j.joms.2010.05.084
Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP (2007) Ameloblastoma. Am J Clin Oncol 30:645–648. doi:10.1097/COC.0b013e3181573e59
McClary AC, West RB, Pollack JR, Fischbein NJ, Holsinger CF, Sunwoo J, Colevas AD, Sirjani D (2015) Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-015-3631-8
Philip M, Morris CG, Werning JW, Mendenhall WM (2005) Radiotherapy in the treatment of ameloblastoma and ameloblastic carcinoma. Hong Kong J Radiol 8:157–161
Mendenhall WM, Riggs CE, Vaysberg M, Amdur RJ, Werning JW (2010) Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. Head Neck 32:939–945. doi:10.1002/hed.21261
Kaye FJ, Ivey AM, Drane WE, Mendenhall WM, Allan RW (2015) Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst 107:378. doi:10.1093/jnci/dju378
Sehdev MK, Huvos AG, Strong EW, Gerold FP, Willis GW (1974) Proceedings: ameloblastoma of maxilla and mandible. Cancer 33:324–333
Olaitan AA, Adeola DS, Adekeye EO (1993) Ameloblastoma: clinical features and management of 315 cases from Kaduna, Nigeria. J Craniomaxillofac Surg 21:351–355
Robinson HB (1937) Ameloblastoma: a survey of 379 cases from the literature. Arch Pathol Lab Med 23
Atkinson CH, Harwood AR, Cummings BJ (1984) Ameloblastoma of the jaw. A reappraisal of the role of megavoltage irradiation. Cancer 53:869–873
Miyamoto CT, Brady LW, Markoe A, Salinger D (1991) Ameloblastoma of the jaw. Treatment with radiation therapy and a case report. Am J Clin Oncol 14:225–230
Pinsolle J, Michelet V, Coustal B, Siberchicot F, Michelet FX (1995) Treatment of ameloblastoma of the jaws. Arch Otolaryngol Head Neck Surg 121:994–996
Gall JA, Sartiano GP, Shreiner DP (1975) Ameloblastoma of the mandible with pulmonary metastasis. Oncology 32:118–126
Campbell D, Jeffrey RR, Wallis F, Hulks G, Kerr KM (2003) Metastatic pulmonary ameloblastoma. An unusual case. Br J Oral Maxillofac Surg 41:194–196
Ramadas K, Jose CC, Subhashini J, Chandi SM, Viswanathan FR (1990) Pulmonary metastases from ameloblastoma of the mandible treated with cisplatin, adriamycin, and cyclophosphamide. Cancer 66:1475–1479
Kurppa KJ, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K (2014) High frequency of BRAF V600E mutations in ameloblastoma. J Pathol 232:492–498. doi:10.1002/path.4317
Arslan H, Akcay M, Yasa B, Hatirli H, Saygili G (2015) Bleaching effect of activation of hydrogen peroxide using photon-initiated photoacoustic streaming technique. Clin Oral Investig 19:253–259. doi:10.1007/s00784-014-1255-9
Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KS, Betz BL (2014) Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res 20:5517–5526. doi:10.1158/1078-0432.CCR-14-1069
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Kennedy, W.R., Werning, J.W., Kaye, F.J. et al. Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy. Eur Arch Otorhinolaryngol 273, 3293–3297 (2016). https://doi.org/10.1007/s00405-016-3899-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-016-3899-3